Safety of intrathecal injection of Wharton’s jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy

Safety of intrathecal injection of Wharton’s jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy

Animal experiments have confirmed that mesenchymal stem cells can inhibit motor neuron apoptosis and inflammatory factor expression and increase neurotrophic factor expression. Therefore, mesenchymal stem cells have been shown to exhibit prospects in the treatment of amyotrophic lateral sclerosis. H...

Full description

Bibliographic Details
Main Authors: Monika Barczewska, Mariusz Grudniak, Stanisław Maksymowicz, Tomasz Siwek, Tomasz Ołdak, Katarzyna Jezierska-Woźniak, Dominika Gładysz, Wojciech Maksymowicz
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Neural Regeneration Research
Subjects:
amyotrophic lateral sclerosis; stem cells therapy; intrathecal injections; Wharton′s jelly-derived mesenchymal stem cells; adverse events; safety; cerebrospinal fluid; neural regeneration
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2019;volume=14;issue=2;spage=313;epage=318;aulast=Barczewska

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2019;volume=14;issue=2;spage=313;epage=318;aulast=Barczewska

Similar Items